
Glimnox M Plus 1mg/1000mg Tablet SR
Marketer
Noxin Biocare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (1000mg)
Overview Glimnox M Plus 1mg/1000mg Tablet SR
Diabexe Duo 1mg/1000mg Extended-Release Tablets are antidiabetic medications combining two active ingredients for adult type 2 diabetes management. This formulation aids in regulating blood glucose. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including a healthy diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or breastfeeding individuals should consult their doctor. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Uses of Glimnox M Plus 1mg/1000mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimnox M Plus 1mg/1000mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glimnox M Plus 1mg/1000mg Tablet SR. Ingest the tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with a meal.
Common Side effects of Glimnox M Plus 1mg/1000mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimnox M Plus 1mg/1000mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimnox M Plus 1mg/1000mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet with a meal.
How Glimnox M Plus 1mg/1000mg Tablet SR works:
Glimnox M Plus 1mg/1000mg Extended-Release tablets combine glimepiride and metformin, two agents effective in diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Glimnox M Plus 1mg/1000mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Glimnox M Plus 1mg/1000mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingUNSAFE
Breastfeeding mothers should not use Glimnox M Plus 1mg/1000mg SR tablets. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimnox M Plus 1mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimnox M Plus 1mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. Individuals with severe liver disease should avoid this medication. A lower starting dose is typically advised for those with mild to moderate liver dysfunction. Physician consultation is essential.
What if you forget to take Glimnox M Plus 1mg/1000mg Tablet SR :
Should you forget a Glimnox M Plus 1mg/1000mg SR Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimnox M Plus 1mg/1000mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
